These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1342 related items for PubMed ID: 15384015

  • 1. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
    Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S.
    Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan.
    Iseki K, Ikemiya Y, Kinjo K, Iseki C, Takishita S.
    Clin Exp Nephrol; 2004 Sep; 8(3):250-6. PubMed ID: 15480903
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP, Leung KT, Tong MK, Kwan TH.
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.
    Jafar TH, Schmid CH, Stark PC, Toto R, Remuzzi G, Ruggenenti P, Marcantoni C, Becker G, Shahinfar S, De Jong PE, De Zeeuw D, Kamper AL, Strangaard S, Levey AS.
    Nephrol Dial Transplant; 2003 Oct; 18(10):2047-53. PubMed ID: 13679479
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China.
    Nan H, Qiao Q, Dong Y, Gao W, Tang B, Qian R, Tuomilehto J.
    J Rheumatol; 2006 Jul; 33(7):1346-50. PubMed ID: 16821269
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia.
    Lin KC, Tsao HM, Chen CH, Chou P.
    J Rheumatol; 2004 Jun; 31(6):1152-8. PubMed ID: 15170929
    [Abstract] [Full Text] [Related]

  • 15. Hyperuricemia and the metabolic syndrome in Hangzhou.
    Cai Z, Xu X, Wu X, Zhou C, Li D.
    Asia Pac J Clin Nutr; 2009 Jun; 18(1):81-7. PubMed ID: 19329400
    [Abstract] [Full Text] [Related]

  • 16. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
    Neri L, Rocca Rey LA, Lentine KL, Hinyard LJ, Pinsky B, Xiao H, Dukes J, Schnitzler MA.
    Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
    [Abstract] [Full Text] [Related]

  • 17. J-shaped mortality relationship for uric acid in CKD.
    Suliman ME, Johnson RJ, García-López E, Qureshi AR, Molinaei H, Carrero JJ, Heimbürger O, Bárány P, Axelsson J, Lindholm B, Stenvinkel P.
    Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.
    Tsui JI, Vittinghoff E, Shlipak MG, Bertenthal D, Inadomi J, Rodriguez RA, O'Hare AM.
    Arch Intern Med; 2007 Jun 25; 167(12):1271-6. PubMed ID: 17592100
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.